HDAC9 and melanoma: Microphthalmia-associated transcription factor (MITF) is repressed by HDAC inhibitor drugs in multiple cell types [35] and its expression is elevated in melanoma skin samples, wherein its activity may play a role in pathogenesis and treatment resistance [36].